Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306.
N Engl J Med. 2005.
PMID: 16236737
Free article.
Clinical Trial.